Definitive(DH)

持股变动声明

Definitive(DH)02-17 05:25

$Definitive(DH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-004114  Size: 5 KB 网页链接

员工持股计划

Definitive(DH)02-29 19:15

$Definitive(DH)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-051102  Act: 33  Size: 67 KB 网页链接

持股变动声明

Definitive(DH)02-06 05:35

$Definitive(DH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-002520  Size: 5 KB 网页链接

持股变动声明

Definitive(DH)02-06 05:35

$Definitive(DH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-002521  Size: 5 KB 网页链接

超过5%股东持股披露「修订」

Definitive(DH)02-09 06:35

$Definitive(DH)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-24-000749  Act: 34  Size: 102 KB 网页链接

持股变动声明

Definitive(DH)03-19 04:15

$Definitive(DH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008255  Size: 5 KB 网页链接

股东委托书协议

Definitive(DH)04-10 04:15

$Definitive(DH)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-090780  Act: 34  Size: 3 MB 网页链接

当期报告

Definitive(DH)02-29 05:35

$Definitive(DH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-022110  Act: 34  Size: 1 MB 网页链接

超过5%股东持股披露「修订」

Definitive(DH)02-10 00:35

$Definitive(DH)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001072613-24-000071  Act: 34  Size: 247 KB 网页链接

持股变动声明

Definitive(DH)02-21 05:15

$Definitive(DH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-004340  Size: 8 KB 网页链接

讨论

SeekingBiotech2023-08-14 21:36

$Harmony(HRMY)$ 收购$Zynerba制药(ZYNE)$
HRMY announced a definitive agreement to acquire Zynerba Pharmaceuticals for $1.1059 per share in cash, or $60 million, plus one non-tradeable contingent value right (CVR) per share, to receive potential additional payments of up t...查看全文

讨论

SeekingBiotech2023-07-29 20:30

BIIB and Reata Pharmaceuticals entered into a definitive agreement under which Biogen has agreed to acquire Reata for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3 billion
73亿美金，没看懂$Biogen制药(BIIB)$ 是没有合适并购对象吗。$Reata制...查看全文

讨论

SeekingBiotech2023-06-20 21:02

$DICE Therapeutics(DICE)$
礼来24亿美元收购小分子自免新药。IL-17以及
α4ß7 整合素和 αVß1/αVß6 整合素的口服治疗候选药物。
DICE announced a definitive agreement for LLY to acquire Dice. Lilly will acquire all outstanding shares of DICE for $48/share in cash for ...查看全文

讨论

二十年一百倍2023-05-27 17:03

$开立医疗(SZ300633)$
海外医疗器械销售体系
GPO和IDN模式的比较
GPO（Group Purchasing Organizations）集团采购组织 ：主要目标就是为采购者（主要是医院等机构）同供货商（厂家、经销商等）进行价格谈判，从而为采购者节约成本，GPO组织自己也能从供应商那里赚 取管理费，根据 D...查看全文

读书笔记《可口可乐传》

李正赫2022-09-15 00:18

今天开始阅读可口可乐传，全名For God, Country & Coca-Cola: The Definitive History of the Great American Soft Drink and the Company That Makes It，第三版。
更新在这里。
网页链接查看全文

讨论

用户28964502982022-07-08 16:40

$美鼎生物(VIVO)$ $美鼎生物(VIVO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-189072查看全文

讨论

rafaello2022-05-07 10:20

回复@rafaello: 再加一个，原材料：MilliporeSigma Corp., Burlington, Massachusetts; and Sheboygan, Wisconsin, has been awarded a $136,695,430 definitive contract to establish domestic production capacity of lateral flow membranes for COVID-19 testing,Work will be performed in S...查看全文

讨论

美股大观2021-11-18 21:10

$EverCommerce(EVCM)$ 最近许多美次新股暴跌，大多数是二次增发，业绩都没啥问题，估值本来就不太低倒是真的。$Definitive(DH)$ $DLocal(DLO)$查看全文

股东委托书协议

$Definitive(DH)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-090780  Act: 34  Size: 3 MB 网页链接

其他

$Definitive(DH)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-090791  Act: 34  Size: 738 KB 网页链接

其他

$Definitive(DH)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-090801  Act: 34  Size: 3 MB 网页链接

持股变动声明

$Definitive(DH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008256  Size: 5 KB 网页链接

持股变动声明

$Definitive(DH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008255  Size: 5 KB 网页链接

持股变动声明

$Definitive(DH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008257  Size: 5 KB 网页链接

员工持股计划

$Definitive(DH)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-051102  Act: 33  Size: 67 KB 网页链接

年度财报

$Definitive(DH)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-022134  Act: 34  Size: 18 MB 网页链接

当期报告

$Definitive(DH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-022110  Act: 34  Size: 1 MB 网页链接

持股变动声明

$Definitive(DH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-004340  Size: 8 KB 网页链接